LEADER 03291nam  22005655  450 
001 9910416096503321
005 20220316142057.0
010   $a3-030-56013-9
024 7 $a10.1007/978-3-030-56013-3
035   $a(CKB)4100000011406695
035   $a(MiAaPQ)EBC6321991
035   $a(DE-He213)978-3-030-56013-3
035   $a(PPN)250212315
035   $a(EXLCZ)994100000011406695
100   $a20200829d2020      u|             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBehavioral Pharmacology of the Cholinergic System$b[electronic resource] /$fedited by Mohammed Shoaib, Tanya L. Wallace
205   $a1st ed. 2020.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020.
215   $a1 online resource (250 pages)
225 1 $aCurrent Topics in Behavioral Neurosciences,$x1866-3370 ;$v45
311   $a3-030-56012-0 
327   $aA Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders -- Acetylcholine and Spontaneous Recognition Memory in Rodents and Primates -- Endogenous Acetylcholine and Its Modulation of Cortical Microcircuits to Enhance Cognition -- Cholinergic Signaling Dynamics and Cognitive Control of Attention -- Involvement of Nicotinic Receptors in Working Memory Function -- Nicotinic Receptors Underlying Nicotine Dependence: Evidence fromTransgenic Mouse Models -- Cholinergic Receptors and Addiction -- Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors -- An Evolving Therapeutic Rationale for Targeting the ?7 Nicotinic Acetylcholine Receptor in Autism Spectrum Disorder -- Activators of ?7 nAChR as Potential Therapeutics for Cognitive Impairment.
330   $aThe molecular genetics of the cholinergic system including both muscarinic and nicotinic acetylcholine receptors, cholinesterases, acetylcholine synthesis and release have provided significant insights into potential targeting for pharmacological intervention. Cholinergic drugs are being used or evaluated for the treatment of diseases. Thus, this volume aims to broaden our understanding of the current state of cholinergic mechanisms to enable implementation of novel approaches for the development of more effective treatments.
410  0$aCurrent Topics in Behavioral Neurosciences,$x1866-3370 ;$v45
606   $aNeurosciences
606   $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006
606   $aNeurociència cognitiva$2thub
606   $aSistema nerviós$2thub
606   $aFarmacologia$2thub
608   $aLlibres electrònics$2thub
615  0$aNeurosciences.
615 14$aNeurosciences.
615  7$aNeurociència cognitiva
615  7$aSistema nerviós
615  7$aFarmacologia
676   $a591.188
702   $aShoaib$b Mohammed$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aWallace$b Tanya L$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910416096503321
996   $aBehavioral Pharmacology of the Cholinergic System$92546176
997   $aUNINA